LATEST ARTICLES
- US secures more Lilly COVID-19 antibodies for $275M, but with pandemic funding uncertain this may be a swan song
- Gilead, Sanofi, GSK and more to pay for employees’ abortion-related travel costs after Roe ruling
- With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US
- Johnson & Johnson refreshes ‘Positively Fearless’ HIV campaign with a new digital presence and LGBTQ+ ambassador
- Fujifilm plots $1.6B expansion at CDMO sites in Denmark and Texas, adding 450 jobs
